Valuation (10%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -126.90 | -17.66 |
PEG Ratio (TTM) | -1.27 | -5.55 |
P/S Ratio (TTM) | N/A | 39.37 |
P/B Ratio (TTM) | 1.89 | 5.80 |
P/FCF Ratio (TTM) | -386.56 | -146.37 |
Price to 5YR AVG Earnings Ratio | N/A | -33.89 |
Price to 5YR AVG FCF Ratio | N/A | -1.07 |
Profitability (0%) |
Company | Industry |
---|---|---|
ROA (TTM) | -1.25% | 288.85% |
ROE (TTM) | -1.32% | -4,241.99% |
Net Profit Margin (TTM) | N/A | -1,047.17% |
ROIC 5YR AVG | N/A | -16.16% |
Growth (8%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | -180.65% | -26.85% | N/A |
Revenue | N/A | -33.33% | N/A |
Net Income | -171.92% | 120,953.54% | N/A |
Cash Flow | -39.22% | -52,019.89% | N/A |
Health (33%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 0.19 | 4.94 |
Quick Ratio (TTM) | 0.19 | 4.92 |
D/E Ratio (TTM) | 0.09 | 1.29 |
Interest Coverage (TTM) | N/A | -11.13 |
Piotroski F-Score | 1 | 3 |
Altman Z-Score | 7.02 | 21.02 |
LTL to 5YR AVG FCF | N/A | -0.53 |
Shares Outstanding Growth 5YR AVG | N/A | 889.05% |